Caplice Noel M, Doyle Brendan
Division of Cardiovascular Diseases, Molecular Medicine Program, Mayo Clinic, Rochester, MN 55905, USA.
Stem Cells Dev. 2005 Apr;14(2):122-39. doi: 10.1089/scd.2005.14.122.
The recent discovery of progenitor cells in peripheral blood that can differentiate into endothelial or vascular smooth muscle cells has led to the re-evaluation of many traditionally held beliefs about vascular biology. Most notably, concepts of vascular regeneration and repair, previously considered limited to the proliferation of existing differentiated cells within vascular tissue, have been expanded to include the potential for postnatal vasculogenesis. These cells have since been identified in the bone marrow, heart, skeletal muscle, and other peripheral tissues, including the vasculature itself. The significance of these cells lies not only in developing our understanding of normal vascular biology, but also in the insights they may provide into vascular diseases such as atherosclerosis. In addition, a potential role in therapeutics has already been explored in early clinical trials in humans. The mechanisms underlying the mobilization, target tissue integration, differentiation, and the observed therapeutic benefits of these cells are now being elucidated. It is these mechanisms, and the current understanding of the lineage of these cells, that constitutes the focus of this review.
最近在外周血中发现了能够分化为内皮细胞或血管平滑肌细胞的祖细胞,这导致人们对许多传统上关于血管生物学的观念进行了重新评估。最值得注意的是,血管再生和修复的概念,以前被认为仅限于血管组织内现有分化细胞的增殖,现在已扩展到包括出生后血管生成的可能性。此后,这些细胞已在骨髓、心脏、骨骼肌和其他外周组织中被发现,包括血管系统本身。这些细胞的重要性不仅在于增进我们对正常血管生物学的理解,还在于它们可能为诸如动脉粥样硬化等血管疾病提供的见解。此外,在人类早期临床试验中已经探索了它们在治疗方面的潜在作用。这些细胞的动员、靶组织整合、分化以及所观察到的治疗益处背后的机制目前正在被阐明。正是这些机制以及目前对这些细胞谱系的理解,构成了本综述的重点。